These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 9486275
21. Reserpine attenuates interstitial adenosine-mediated activation of ecto-5'-nucleotidase in rat hearts in vivo. Obata T, Yamanaka Y. Arch Biochem Biophys; 2000 Mar 15; 375(2):333-9. PubMed ID: 10700389 [Abstract] [Full Text] [Related]
22. Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits. Matsusaka T, Hasebe N, Jin YT, Kawabe J, Kikuchi K. Cardiovasc Res; 2002 Jun 15; 54(3):568-75. PubMed ID: 12031702 [Abstract] [Full Text] [Related]
24. Cardiac contractile function during coronary stenosis in dogs: association of adenosine in glycolytic dependence. Fang HK, Sturgeon C, Segil LJ, Ripper RL, Law WR. Am J Physiol; 1997 May 15; 272(5 Pt 2):H2195-203. PubMed ID: 9176286 [Abstract] [Full Text] [Related]
25. Cardioprotection due to preconditioning correlates with increased ecto-5'-nucleotidase activity. Minamino T, Kitakaze M, Morioka T, Node K, Komamura K, Takeda H, Inoue M, Hori M, Kamada T. Am J Physiol; 1996 Jan 15; 270(1 Pt 2):H238-44. PubMed ID: 8769757 [Abstract] [Full Text] [Related]
26. Disparate effects of preconditioning and MLA on 5'-NT and adenosine levels during coronary occlusion. Przyklenk K, Hata K, Zhao L, Kloner RA, Elliott GT. Am J Physiol; 1997 Aug 15; 273(2 Pt 2):H945-51. PubMed ID: 9277514 [Abstract] [Full Text] [Related]
27. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase. Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, Chujo M, Mori H, Inoue M, Hori M, Kamada T. Circulation; 1996 Feb 15; 93(4):781-91. PubMed ID: 8641008 [Abstract] [Full Text] [Related]
28. Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction. Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Inoue M, Tada M, Hori M, Kamada T. Circulation; 1996 Jan 15; 93(2):356-64. PubMed ID: 8548910 [Abstract] [Full Text] [Related]
29. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs. Abe Y, Kitada Y, Narimatsu A. J Pharmacol Exp Ther; 1993 May 15; 265(2):819-25. PubMed ID: 8496827 [Abstract] [Full Text] [Related]
30. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine. Headrick JP. J Mol Cell Cardiol; 1996 Jun 15; 28(6):1227-40. PubMed ID: 8782064 [Abstract] [Full Text] [Related]
31. Preconditioning preserves energy metabolism in prolonged low-flow ischemia. Hoffmeister HM, Ströbele M, Bässler A, Beyer ME, Kazmaier S, Seipel L. Basic Res Cardiol; 1998 Dec 15; 93(6):487-96. PubMed ID: 9879455 [Abstract] [Full Text] [Related]
32. Ischaemic preconditioning is related to decreasing levels of extracellular adenosine that may be metabolically useful in the at-risk myocardium: an experimental study in the pig. Waldenström A, Haney M, Biber B, Kavianipour M, Moritz T, Strandén P, Wikström G, Ronquist G. Acta Physiol (Oxf); 2010 May 15; 199(1):1-9. PubMed ID: 20028345 [Abstract] [Full Text] [Related]
33. Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity. Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H, Inoue M. J Clin Invest; 1994 May 15; 93(5):2197-205. PubMed ID: 8182151 [Abstract] [Full Text] [Related]
34. Pronounced antiarrhythmic effects of preconditioning in anaesthetized dogs: is adenosine involved? Vegh A, Papp JG, Parratt JR. J Mol Cell Cardiol; 1995 Jan 15; 27(1):349-56. PubMed ID: 7760356 [Abstract] [Full Text] [Related]
35. Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockade. Duncker DJ, van Zon NS, Pavek TJ, Herrlinger SK, Bache RJ. J Clin Invest; 1995 Jan 15; 95(1):285-95. PubMed ID: 7814627 [Abstract] [Full Text] [Related]
36. Intracoronary administration of adenosine triphosphate increases coronary blood flow and attenuates the severity of myocardial ischemic injury in dogs. Kitakaze M, Node K, Komamura K, Minamino T, Kosaka H, Kuzuya T, Hori M. Cardiovasc Drugs Ther; 1999 Sep 15; 13(5):407-14. PubMed ID: 10547220 [Abstract] [Full Text] [Related]
37. Role of adenosine in local metabolic coronary vasodilation. Yada T, Richmond KN, Van Bibber R, Kroll K, Feigl EO. Am J Physiol; 1999 May 15; 276(5):H1425-33. PubMed ID: 10330224 [Abstract] [Full Text] [Related]
38. A calcium channel blocker amlodipine increases coronary blood flow via both adenosine- and NO-dependent mechanisms in ischemic hearts. Asanuma H, Minamino T, Sanada S, Ogita H, Kim J, Fujita M, Hirata A, Tsukamoto O, Ogai A, Node K, Hori M, Tomoike H, Kitakaze M. J Mol Cell Cardiol; 2005 Oct 15; 39(4):605-14. PubMed ID: 16087189 [Abstract] [Full Text] [Related]
39. Endogenous adenosine increases O2 utilisation efficiency in isoprenaline-stimulated canine myocardium. Mallet RT, Lee SC, Downey HF. Cardiovasc Res; 1996 Jan 15; 31(1):102-16. PubMed ID: 8849594 [Abstract] [Full Text] [Related]
40. Endogenous adenosine blunts beta-adrenoceptor-mediated inotropic response in hypoperfused canine myocardium. Sato H, Hori M, Kitakaze M, Takashima S, Inoue M, Kitabatake A, Kamada T. Circulation; 1992 Apr 15; 85(4):1594-603. PubMed ID: 1313344 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]